Navigation Links
Smithsonian identifies invasive crab species in Panama Canal expansion area
Date:9/19/2007

A Smithsonian scientist and colleague report that a potentially harmful, invasive crab species that has spread to several countries is now established and reproducing in Panama. The researchers report that Harris mud crabs are reproducing in the small, man-made lake designated to become the third set of locks in Panamas new $5 billion canal expansion project.

Mark Torchin, a staff scientist at the Smithsonian Tropical Research Institute in Panama, and Dominique Roche, a McGill University pre-doctoral student, report their research in the September issue of Aquatic Invasions.

The Harris mud crab, Rhithropanopeus harrisii, native to estuarine environments along the East coast of North America, has spread to at least 21 countries, causing varying degrees of both environmental and economic damage. This mud crab has the potential to disrupt local ecosystems, invade inland freshwater lakes and harbor crustacean diseases. It also fouls pipes and preys upon fish in gill nets.

Torchin and Roche first discovered R. harrisii on the shoreline of the Miraflores Third Lock Lake in February. In March, they collected males, egg-bearing females and juveniles. While individual Harris mud crabs were reported from Panama in 1969, this is the first report of an established and reproducing population in the country.

The Miraflores Third Lock Lake was created in the early 1940s, during an aborted project to further expand the canal. The new canal expansion project, formally inaugurated Sept. 3, will reconnect this lake to the waterway.

Additional surveys will determine whether the crab is ubiquitous in the canal waters and if it is established at other sites. Genetic analysis will reveal the origin of this population and will determine if all populations in the canal are related or whether they result from independent introductions. The Panama Canal Authority supports STRIs survey efforts.

This study is part of a major ongoing project by Torchin and
'/>"/>

Contact: Beth King
kingb@si.edu
7-037-873-772-8216
Smithsonian Tropical Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Smithsonian scientists discover new marine species in eastern Pacific
2. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
3. New lab technique identifies high levels of pathogens in therapy pool
4. Study identifies gene in mice that may control risk-taking behavior in humans
5. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
6. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
7. Model identifies genes that induce normal skin cells to become abnormal
8. New study identifies key gene in development of connections between brain and spinal cord
9. New HIV study identifies high-risk subgroups of adolescents
10. Research identifies protein in mice that regulates bone formation
11. Study identifies new role for breast cancer susceptibility gene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... Hole Research Center are analyzing the surprising results of the ... rainforest. , From January 2000 to July 2004, rainfall was ... of the Tapajós National Forest, in Brazil. A total of ... by 6' clear plastic panels suspended 3 to 12 feet ...
... Affymetrix Inc. (Nasdaq: AFFX - News) and Karolinska ... a strategic alliance designed to improve healthcare by ... tools for better diagnosis, prognosis, and treatment. , ... genetic analyses and measurement of gene expression in ...
... have discovered an important chemical in the brain's ... symptoms of opioid drugs like morphine and heroin. ... chemical--called a transporter--could relieve some of the early ... shaking, and jumpiness. Such drugs could become part ...
Cached Biology News:World's largest rainforest drying experiment completes first phase 2World's largest rainforest drying experiment completes first phase 3Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 2Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 3Key Trigger Of Opioid Withdrawal Symptoms Found 2
(Date:9/1/2015)... Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... th Annual Global Investment Conference sponsored by ... 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide an ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative ... assays that use 3D cellular models such as spheroids, tissues, and organisms. ...
(Date:9/1/2015)... ... September 01, 2015 , ... AxioMx Inc. , a ... Institutes of Health (NIH) has awarded the company a Phase I Small Business ... Institute of Diabetes and Digestive and Kidney Diseases. AxioMx will use this award ...
(Date:9/1/2015)... The Dohmen Company today announced the ... as Chief Science Officer (CSO) of Dohmen Life ... Dr. Floyd will lead Dohmen,s growing regulatory consulting ... and post approval outsourced services in quality, regulatory, ... Floyd brings decades of experience leading global regulatory ...
Breaking Biology Technology:ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3
... Brain Metastases, PALO ALTO, Calif., Sept. 2 ... radiosurgery treatments for,multiple brain metastases using new RapidArc ... ). The MIMA Cancer Center in Melbourne,Florida and ... able to treat brain metastases more quickly and ...
... BMRN ) today announced that Jean-Jacques,Bienaime, Chief Executive ... 3rd Annual Citi Biotech Day in New York City ... Interested parties may access a live audio webcast of ... website, http://www.BMRN.com .,A replay of the call will ...
... development milestone payment to InterMune - ... to lead ITMN-191 program in Phase 2 -, BRISBANE, ... announced that InterMune has earned a $15 million,development milestone under ... NS3 protease inhibitor compound ITMN-191,(referred to as R7227 at Roche), ...
Cached Biology Technology:Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 4BioMarin to Present at the Citi Biotech Day 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4